title: Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
authors.forename: Marja-Riitta
authors.initials: MR
authors.lastname: Taskinen
mesh_terms: D008076:Cholesterol, HDL / Q000097:blood; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D016032:Randomized Controlled Trials as Topic
chemical_list: D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D011345:Fenofibrate